• Profile
Close

Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - Results from the CHIKARA study

International Journal of Rheumatic Diseases Sep 10, 2018

Tada M, et al. - In a prospective, observational study (CHIKARA study) of rheumatoid arthritis (RA) patients, experts gauged the associations between sarcopenia and disease activity, physical function, laboratory data, and body composition at baseline. In patients with RA whose disease activity was mild, the prevalence of sarcopenia was 28%. Findings suggested an independent association of low BMI, high-fat mass and high MMP3 with sarcopenia. A useful marker for sarcopenia in patients with RA could be MMP3. They noted an increase of 3.1-fold compared with < 90.7 ng/mL in the odds ratio for sarcopenia when MMP3 was ≥ 90.7 ng/mL.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay